Daniel Saha

Learn More
MOTIVATION Mass spectrometric profiles of peptides and proteins obtained by current technologies are characterized by complex spectra, high dimensionality and substantial noise. These characteristics generate challenges in the discovery of proteins and protein-profiles that distinguish disease states, e.g. cancer patients from healthy individuals. We(More)
Serum profiling using mass spectrometry is an emerging technology with a great potential to provide biomarkers for complex diseases such as cancer. However, protein profiles obtained from current mass spectrometric technologies are characterized by their high dimensionality and complex spectra with substantial level of noise. These characteristics have(More)
  • 1